This Week in Startups Building a blood-testing startup in 2023 with Vital CEO Vasu Nadella | E1801
Sep 4, 2023
Vasu Nadella, CEO and co-founder of Vital Biosciences, shares his insights on revolutionizing blood testing with the VitalOne device, capable of conducting over 50 tests from a tiny blood sample. He discusses trust-building with investors after industry failures, the mission to enhance healthcare accessibility, and innovative tech's role in diagnostics. Vasu also explores the integration of AI and robotics in lab settings, emphasizing a shift toward proactive health management and the importance of transparency in patient care.
AI Snips
Chapters
Transcript
Episode notes
Vasu's Motivation
- Vasu Nadella's interest in blood testing stems from family experiences with chronic diseases and lab testing frustrations.
- He witnessed the dread of waiting for results and the broken healthcare system's impact on patients and doctors.
Healthcare's Missing Software Moment
- Vasu views Vital Biosciences as a care delivery startup, not just blood testing.
- He believes the lack of a "software moment" in healthcare is due to the limitation of physical connections and processes.
Complexity Placement
- Place complexity in the microfluidic platform, which is disposable.
- Leverage existing supply chains and know-how for molding plastic discs for reliability.